These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10108250)

  • 1. A cost comparison of intravenous cimetidine delivery systems.
    Jackson CW; Caldwell RD; Arford PD
    Hosp Pharm; 1990 Dec; 25(12):1085-9. PubMed ID: 10108250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and acceptability of three syringe-pump infusion systems.
    Johnson MS; Pesko LJ; Wood CF; Reinders TP
    Am J Hosp Pharm; 1990 Aug; 47(8):1794-8. PubMed ID: 2389788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringes versus minibags as an intravenous admixture system: a comparison of cost and nursing preference.
    Gin A; Martens D; Dobson K; Hall K
    Can J Hosp Pharm; 1987 Jun; 40(3):81-5. PubMed ID: 10282581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of seven methods of preparing and administering small-volume injections.
    Smith CF; Amen RJ
    Am J Hosp Pharm; 1988 Sep; 45(9):1896-901. PubMed ID: 3228122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated administration of intermittent intravenous doses.
    Lutomski DM; Schwartz-Fulton J; Rivera JO
    Am J Hosp Pharm; 1985 Nov; 42(11):2514-7. PubMed ID: 4073071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost comparison of oral, nasogastric, and intramuscular cimetidine drug delivery systems.
    Lau NC; Caldwell RD; Arford PH
    Hosp Pharm; 1992 Nov; 27(11):946-7, 950-2, 954-6 passim. PubMed ID: 10122039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a multiple-dose syringe pump system for intermittent i.v. drug delivery.
    Hola ET; Cronin CM; DeMonaco HJ; Franco ER; Pauley SY
    Am J Hosp Pharm; 1986 Oct; 43(10):2474-8. PubMed ID: 3788999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost comparison of two systems for intermittent intravenous administration of small-volume injections.
    Reilly RT; Strand LM; Bair JN
    Am J Hosp Pharm; 1985 Feb; 42(2):323-8. PubMed ID: 3976678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A financial evaluation of the Becton Dickinson 360 infuser system.
    Fiorenzo VJ; Kelly WN
    Hosp Pharm; 1987 Jun; 22(6):563-6. PubMed ID: 10312122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of drug distribution costs for controlled versus noncontrolled oral analgesics.
    Reynolds RC; Ploetz P; Thielke TS
    Am J Hosp Pharm; 1984 Aug; 41(8):1558-63. PubMed ID: 6475974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcost analysis of inpatient dispensing and administration of oral solids.
    Hatoum HT
    Am J Hosp Pharm; 1990 Apr; 47(4):800-5. PubMed ID: 2321657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication cart-filling time, accuracy, and cost with an automated dispensing system.
    Klein EG; Santora JA; Pascale PM; Kitrenos JG
    Am J Hosp Pharm; 1994 May; 51(9):1193-6. PubMed ID: 8042638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An economic comparison of Tubex injection systems with traditional ampuls and vials.
    Miller DE; Grainger WL; Woolard D; Timko JR; Adler DC
    Hosp Pharm; 1985 Aug; 20(8):584-91, 595. PubMed ID: 10272398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving medication administration systems: an evaluation study.
    Bennett J; Harper-Femson LA; Tone J; Rajmohamed Y
    Can Nurse; 2006 Oct; 102(8):35-9. PubMed ID: 17094367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential cost-avoidance with oral extended-release morphine sulfate tablets versus morphine sulfate solution.
    Goughnour BR; Arkinstall WW
    Am J Hosp Pharm; 1991 Jan; 48(1):101-4. PubMed ID: 2000864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economics of providing antineoplastic drugs in a manufacturer-mixed bulk package.
    Kleinberg ML; Duafala ME
    Am J Hosp Pharm; 1988 Jan; 45(1):109-15. PubMed ID: 3348222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costing services: comparing three i.v. medication systems.
    Baker K; Evans CB; Tiburzi T; Nolan MT; Frost GL; Kokoski P; Arrington DM
    Nurs Manage; 1993 Mar; 24(3):56-60. PubMed ID: 8455896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining drug dispensing costs for use in cost-accounting systems.
    Thielke TS; Charlson JT; Heckethorn D
    Am J Hosp Pharm; 1988 Apr; 45(4):844-7. PubMed ID: 3376969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine: a cost-effective alternative to Schedule II analgesics for moderate to severe pain relief.
    Rosenthal MH; Bayait F
    Hosp Formul; 1988 Jan; 23(1):57-60, 62, 71. PubMed ID: 10312332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.